MiMedx Group Inc (MDXG)

Business: MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.

IPO Date: 22-Aug-2007

CEO & Director: Mr. Timothy R. Wright MBA

Chief Financial Officer: Mr. Peter Martin Carlson CPA

Listing: NASDAQ: MDXG

Country: United States

Headquarters: Marietta, GA

Website: https://www.mimedx.com

Market cap: $404.67 Mln

Revenue (TTM): $257.54 Mln

Earnings (TTM): $-12.51 Mln

Cash: $75.68 Mln

Total Debt: $48.24 Mln

Insider's Holding: 1.98%

Liquidity: Low

52 Week range: $3.04 - 15.99

Shares outstanding: 113,353,000

10 Years Aggregate:

• CFO: $148.98 Mln
• EBITDA: $89.37 Mln
• Net Profit: $-6.81 Mln